03
Dec
2008
Ascent Therapeutics, Inc.: Series A $19M
Posted in I - Series A, Q - 4Q08, R - NORTH EAST, X - G-Protein
Ascent Therapeutics (Cambridge, MA) early-stage developer of G-protein coupled receptor target modulator therapeutics, closed a $19M Series A financing. Participants include Novartis Option Fund, Healthcare Ventures and TVM Capital.
OnBioVC PARTNERS
-
